EP3198040A1 - Probiotic fermented feed additives - Google Patents
Probiotic fermented feed additivesInfo
- Publication number
- EP3198040A1 EP3198040A1 EP15784768.2A EP15784768A EP3198040A1 EP 3198040 A1 EP3198040 A1 EP 3198040A1 EP 15784768 A EP15784768 A EP 15784768A EP 3198040 A1 EP3198040 A1 EP 3198040A1
- Authority
- EP
- European Patent Office
- Prior art keywords
- lab
- mscl
- feed
- baltbio02
- lactic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000003674 animal food additive Substances 0.000 title claims abstract description 12
- 239000006041 probiotic Substances 0.000 title claims abstract description 9
- 235000018291 probiotics Nutrition 0.000 title claims abstract description 9
- 230000000529 probiotic effect Effects 0.000 title claims abstract description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims abstract description 40
- 241000191996 Pediococcus pentosaceus Species 0.000 claims abstract description 37
- 241000191998 Pediococcus acidilactici Species 0.000 claims abstract description 32
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- 239000004310 lactic acid Substances 0.000 claims abstract description 20
- 235000014655 lactic acid Nutrition 0.000 claims abstract description 20
- 238000004519 manufacturing process Methods 0.000 claims abstract description 16
- 239000000463 material Substances 0.000 claims abstract description 6
- 150000001875 compounds Chemical class 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 12
- 230000001580 bacterial effect Effects 0.000 claims description 10
- 244000005700 microbiome Species 0.000 claims description 7
- 235000011389 fruit/vegetable juice Nutrition 0.000 claims description 4
- 244000061456 Solanum tuberosum Species 0.000 claims description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000013589 supplement Substances 0.000 claims 2
- 230000000845 anti-microbial effect Effects 0.000 abstract description 12
- 235000013339 cereals Nutrition 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 4
- 230000003862 health status Effects 0.000 abstract description 4
- 230000004071 biological effect Effects 0.000 abstract description 3
- 239000006052 feed supplement Substances 0.000 abstract description 2
- 239000002994 raw material Substances 0.000 abstract description 2
- 235000013336 milk Nutrition 0.000 description 22
- 239000008267 milk Substances 0.000 description 22
- 210000004080 milk Anatomy 0.000 description 22
- 238000002474 experimental method Methods 0.000 description 19
- 241000283690 Bos taurus Species 0.000 description 17
- 229920001817 Agar Polymers 0.000 description 10
- 239000008272 agar Substances 0.000 description 10
- 239000007858 starting material Substances 0.000 description 10
- 238000000855 fermentation Methods 0.000 description 9
- 230000004151 fermentation Effects 0.000 description 9
- 239000002609 medium Substances 0.000 description 9
- 238000000034 method Methods 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 7
- 239000008280 blood Substances 0.000 description 7
- 244000309466 calf Species 0.000 description 7
- 230000000694 effects Effects 0.000 description 7
- 239000002207 metabolite Substances 0.000 description 7
- 241000192001 Pediococcus Species 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 5
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 5
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 5
- 239000008101 lactose Substances 0.000 description 5
- 244000144972 livestock Species 0.000 description 5
- 244000005706 microflora Species 0.000 description 5
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 4
- 102000004625 Aspartate Aminotransferases Human genes 0.000 description 4
- 108010003415 Aspartate Aminotransferases Proteins 0.000 description 4
- 241000193388 Bacillus thuringiensis Species 0.000 description 4
- 108010062877 Bacteriocins Proteins 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 4
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 4
- 239000000654 additive Substances 0.000 description 4
- 230000000996 additive effect Effects 0.000 description 4
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 4
- 244000052616 bacterial pathogen Species 0.000 description 4
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 4
- 230000005764 inhibitory process Effects 0.000 description 4
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- 241000194031 Enterococcus faecium Species 0.000 description 3
- 241000233866 Fungi Species 0.000 description 3
- 241000186660 Lactobacillus Species 0.000 description 3
- 240000006024 Lactobacillus plantarum Species 0.000 description 3
- 235000013965 Lactobacillus plantarum Nutrition 0.000 description 3
- 241000218588 Lactobacillus rhamnosus Species 0.000 description 3
- 230000000844 anti-bacterial effect Effects 0.000 description 3
- 230000003385 bacteriostatic effect Effects 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 229940023064 escherichia coli Drugs 0.000 description 3
- 235000013312 flour Nutrition 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 150000003893 lactate salts Chemical class 0.000 description 3
- 229940039696 lactobacillus Drugs 0.000 description 3
- 229940072205 lactobacillus plantarum Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 230000002269 spontaneous effect Effects 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- UHPMCKVQTMMPCG-UHFFFAOYSA-N 5,8-dihydroxy-2-methoxy-6-methyl-7-(2-oxopropyl)naphthalene-1,4-dione Chemical compound CC1=C(CC(C)=O)C(O)=C2C(=O)C(OC)=CC(=O)C2=C1O UHPMCKVQTMMPCG-UHFFFAOYSA-N 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- 241000228245 Aspergillus niger Species 0.000 description 2
- 235000007319 Avena orientalis Nutrition 0.000 description 2
- 244000075850 Avena orientalis Species 0.000 description 2
- 102000016938 Catalase Human genes 0.000 description 2
- 108010053835 Catalase Proteins 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 241000194032 Enterococcus faecalis Species 0.000 description 2
- 241000223218 Fusarium Species 0.000 description 2
- 241001489200 Fusarium poae Species 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 241001084338 Listeria sp. Species 0.000 description 2
- 241000192041 Micrococcus Species 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 241000178960 Paenibacillus macerans Species 0.000 description 2
- 241000228150 Penicillium chrysogenum Species 0.000 description 2
- 241000589516 Pseudomonas Species 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241001354013 Salmonella enterica subsp. enterica serovar Enteritidis Species 0.000 description 2
- 235000007238 Secale cereale Nutrition 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 241000191967 Staphylococcus aureus Species 0.000 description 2
- 241000209140 Triticum Species 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 241000607447 Yersinia enterocolitica Species 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 229940097012 bacillus thuringiensis Drugs 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 235000020247 cow milk Nutrition 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 239000012895 dilution Substances 0.000 description 2
- 238000010790 dilution Methods 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 229940032049 enterococcus faecalis Drugs 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 244000005709 gut microbiome Species 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 238000005070 sampling Methods 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000001082 somatic cell Anatomy 0.000 description 2
- 229960005322 streptomycin Drugs 0.000 description 2
- 229940098232 yersinia enterocolitica Drugs 0.000 description 2
- 108020004465 16S ribosomal RNA Proteins 0.000 description 1
- 208000010444 Acidosis Diseases 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 241000252983 Caecum Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282414 Homo sapiens Species 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- IFQSXNOEEPCSLW-DKWTVANSSA-N L-cysteine hydrochloride Chemical compound Cl.SC[C@H](N)C(O)=O IFQSXNOEEPCSLW-DKWTVANSSA-N 0.000 description 1
- 241001134659 Lactobacillus curvatus Species 0.000 description 1
- 241000186841 Lactobacillus farciminis Species 0.000 description 1
- 241000186612 Lactobacillus sakei Species 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 241000191936 Micrococcus sp. Species 0.000 description 1
- 102000014171 Milk Proteins Human genes 0.000 description 1
- 108010011756 Milk Proteins Proteins 0.000 description 1
- 241000606860 Pasteurella Species 0.000 description 1
- 241000228143 Penicillium Species 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- 108010064851 Plant Proteins Proteins 0.000 description 1
- 241000607142 Salmonella Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 241000191940 Staphylococcus Species 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- 229930003779 Vitamin B12 Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- 230000007950 acidosis Effects 0.000 description 1
- 208000026545 acidosis disease Diseases 0.000 description 1
- 230000003321 amplification Effects 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 210000004534 cecum Anatomy 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 238000000151 deposition Methods 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000000855 fungicidal effect Effects 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000008774 maternal effect Effects 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 238000011206 morphological examination Methods 0.000 description 1
- 239000006872 mrs medium Substances 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 238000003199 nucleic acid amplification method Methods 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 235000021118 plant-derived protein Nutrition 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- YWYZEGXAUVWDED-UHFFFAOYSA-N triammonium citrate Chemical compound [NH4+].[NH4+].[NH4+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YWYZEGXAUVWDED-UHFFFAOYSA-N 0.000 description 1
- 239000001393 triammonium citrate Substances 0.000 description 1
- 235000011046 triammonium citrate Nutrition 0.000 description 1
- 239000012137 tryptone Substances 0.000 description 1
- 230000035899 viability Effects 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000019163 vitamin B12 Nutrition 0.000 description 1
- 239000011715 vitamin B12 Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K30/00—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs
- A23K30/10—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder
- A23K30/15—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging
- A23K30/18—Processes specially adapted for preservation of materials in order to produce animal feeding-stuffs of green fodder using chemicals or microorganisms for ensilaging using microorganisms or enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
- A23K10/12—Animal feeding-stuffs obtained by microbiological or biochemical processes by fermentation of natural products, e.g. of vegetable material, animal waste material or biomass
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K10/00—Animal feeding-stuffs
- A23K10/30—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms
- A23K10/35—Animal feeding-stuffs from material of plant origin, e.g. roots, seeds or hay; from material of fungal origin, e.g. mushrooms from potatoes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
Definitions
- the present invention relates to biotechnologies and is intended for the field of feed production and may be applied for producing preparations of high antimicrobial activity, i.e. fermented feed additives, feed supplements, feed premixtures, feed materials and compound feeds.
- Lactic acid bacteria are normally considered to be beneficial (nonpathogenic) microorganisms which live in various environments such as that of soil, plants, insects, animals and human microflora. These microorganisms are antagonistic to decay microflora and excrete a lactic acid as well as the substances which are identical to antibiotics, i.e. bacteriocins or substances similar to bacteriocins. Lactic acid bacteria promote the synthesis of B-group vitamins (biotin, thiamine, riboflavin, nicotinic acid, vitamin B12) and the vitamin K.
- B-group vitamins biotin, thiamine, riboflavin, nicotinic acid, vitamin B12
- lactic acid bacteria reaches the peak when the pH level of the media is 4-5.
- Their spectrum of activity includes many pathogenic bacteria: Escherichia Coli, Salmonella, Shigella, Pasteurella, Bacillus and Staphylococcus.
- Probiotics of lactic acid bacteria normalize the livestock gastrointestinal microflora, stimulate digestive processes, help their bodies to assimilate the nutrients contained in a feed, have influence on the livestock resistance to infections and their yield.
- Pediococcus spp. One of the most perspective genera of LAB is Pediococcus spp. and, in particular, two closely related group bacteria of this genus Pediococcus pentosaceus and Pediococcus acidilactici. Their brief morphological description is provided in the manual (Bergey's Manual of Systematic Bacteriology, vol.3, Furmicutes, Springer, 2009 p.p. 518, 519). The use of these bacteria in the production of fermented feed is known.
- the production method of dry (solid) fermented feeds is known (see the patent WO2013029682). It suggests to use one or several LAB from the group Enterococcus faecium, Lactobacillus rhamnosus, Lactobacillus plantarum, Pediococcus acidililactili and Pediococcus pentosaceus.
- the method and equipment of drying of fermented feeds is widely described in this invention.
- the disadvantage of this invention is high temperature necessary for drying fermented feeds: the temperature of the air supplied to the drying chamber exceeds +120°C, and the temperature of the dried fermented feeds exceeds +40°C; this significantly reduces the viability of probiotic bacteria.
- the homofermented liquid feeds and the methods of their production are also known (see the patent EP2056681). It suggests to use the same LAB in fermented feed production as the abovementioned invention, however, it additionally indicates specific LAB strains, i.e. Enterococcus faecium MCIMB 30122, Lactobacillus rhamnosus NCIMB 30121, Lactobacillus plantarum LSI (NCIMB 30083), Pediococcus acidililactili NCIMB 30086 and Pediococcus pentosaceus HTS (LMG P- 22549).
- the described method of production and formulas are not suitable for dry fermented feed production.
- the closest analogue for the proposed invention is described in the patent US20140037786. It is the method of dry fermented feed production in which such LAB strains as Enterococcus faecium MCIMB 30122, Lactobacillus rhamnosus NCIMB 30121, Lactobacillus plantarum LSI (NCIMB 30083), Pediococcus acidililactili NCIMB 30086 and Pediococcus pentosaceus HTS (LMG P-22549) are used.
- LAB strains as Enterococcus faecium MCIMB 30122, Lactobacillus rhamnosus NCIMB 30121, Lactobacillus plantarum LSI (NCIMB 30083), Pediococcus acidililactili NCIMB 30086 and Pediococcus pentosaceus HTS (LMG P-22549) are used.
- the objective of the invention is production of the fermented feed additives of high biological activity by using the newly selected LAB strains isolated from the spontaneously fermented cereal material. This objective is achieved by using, together or separately, the LAB Pediococcus acidilactici BaltBioOl and/or Pediococcus pentosaceus BaltBio02 in production of fermented feed additives.
- the BaltBio lactic acid bacteria strains are isolated from the starter cultures of the spontaneously fermented cereal crops grown in Lithuania. The technical works of isolation of the strains have been performed by UAB Bioseka under contracts. The strains have been identified by UAB Biosta.
- the starter cultures were produced under the laboratory conditions by changing the moisture content of the medium and the temperature of fermentation.
- the starter cultures were prepared from rye flour type 1370, oat flour and water in the ratio of 1 : 1 or 1:2, the temperature was cyclically varied within the range from 25 to 35 °C.
- the modified MRS medium (mMRS) was prepared by dissolving 10.0 g of tryptone peptone and meat extract, 5.0 g of yeast extract and sodium acetate, 7.0 g of glucose, fructose and maltose, 2.0 g of sodium glyconate, K2HPO4 and triammonium citrate, 1.0 ml of Tween 80, 0.2 g of MgS0 4 -7 H 2 0, 0.05 g of MnS0 4 -4 H 2 0, 0.5 g of cystein chloride, 15.0 g of agar in 1 1 of distilled water. The obtained solution (pH 6.3) was sterilized for 15 min at the temperature of 121 °C.
- the MRS agar medium (MRS) was prepared by dissolving 66.2 g of MRS agar in 1 1 of distilled water. The obtained solution was boiled until the agar was completely dissolved and sterilized for 15 min at the temperature of 118 °C.
- the LAB were characterized by identifying their morphology by performing the tests of carbohydrate fermentation and growth at different temperatures.
- Cocci were divided into two groups on the basis of sucrose and maltose fermentation: the first group consisted of 26, and the second group consisted of 10 bacterial strains. All spherical- shaped bacteria hydrolyzed trehalose and glucose. It is known that P. pentosaceus and P. acidilactici differ in fermentation of maltose and trehalose and their potential for growth is also different at the temperature of 50°C, P. pentosaceus ferment both carbohydrates and are unable to grow at the said temperature, while P. acidilactici ferment only trehalose and are able to grow at the temperature of 50 °C.
- bacteriocins of the isolated strains P. acidilactici and P. pentosaceus against pathogenic microorganisms Bacillus thuringiensis, Escherichia coli, Enterococcus faecalis, Staphylococcus aureus, Bacillus macerans, Salmonella enteritidis, Micrococcus sp, Yersinia enterocolitica, Listeria sp., Pseudomonas aeroginosa), Pediococcus acidilactici BaltBioOl and Pediococcus pentosaceus BaltBio02 were selected as the most promising microorganisms for ensuring good health of animals by using them for feed additives and other feed products.
- the antimicrobial activity of metabolites of the selected lactic acid bacteria P. acidilactici BaltBioOl, P. pentosaceus BaltBio02 against pathogenic bacteria (Bacillus thuringiensis, Escherichia coli, Enterococcus faecalis, Staphylococcus aureus, Bacillus macerans, Salmonella enteritidis, Micrococcus sp, Yersinia enterocolitica, Listeria sp., Pseudomonas aeroginosa) has been found.
- LAB lactic acid bacteria
- LAC are able to completely stop the growth of pathogenic bacteria (bactericidal effect) or inhibit or partly inhibit their growth (bacteriostatic effect).
- the antimicrobial effect of the LAC strains against Gram-/+ bacteria depended on the LAB strain and indicator microorganism.
- P. acidilactici BaltBioOl demonstrated the bactericidal effect against all examined indicator bacteria (measured diameter of the zones of inhibition in the agar medium varied from 10 ⁇ 0 to 24.5 ⁇ 0.7 mm), while P. pentosaceus BaltBio02 demonstrated the bacteriostatic effect.
- the LAB metabolites demonstrated fungistatic and fungicidal effect on the growth of Fusarium poae, while the LAB had only fungistatic effect on the growth of Penicillium chrysogenum and Aspergillus niger.
- LAB Prior to experiment, LAB were kept at the temperature of -70°C (Sanyo, Japan). The thawed LAB were amplified in MRS agar (Sigma Aldrich, Germany) or any other alternative medium by keeping P. pentosaceus BaltBio02 at the temperature of 35 °C and P. acidilactici BaltBioOl - at the temperature of 32 °C for 48 hours, until the level of LAB reached 10 8 -10 9 CFU/ml.
- the pure LAB are amplified in the alternative medium which is made of potato juice by autoclaving them, cooling to a temperature of 30°C and introducing pure LAB cultures (1 ml pure bacteria cultures amplified in MRS bouillon into 0.5 litre of juice).
- the alternative medium with LAB is kept at the temperature of 30 +/- 2 °C for 24; 48 and 72 hours, until the level of LAB reaches 9.60xl0 10 CFU/ml.
- LAB prepared for fermentation may comprise from 0.5% to 10% of the substratum prepared before fermentation.
- P. acidilactici BaltBioOl or P. pentosaceus BaltBio02 or their mixture may be used.
- the recommended duration of fermentation is from 8 hours to 72 hours and the temperature shall be from 20°C to 40°C.
- Biologically active fermented feed additive shall contain LAB from 10 6 to 10 9 CUF/g and pH shall be from 3.0 to 6.0.
- Example 1 Assessment of the Effect of the Product Fermented by the Mixture of Lactic Acid Bacteria Pediococcus Acidilactici BaltbioOl and Pediococcus Pentosaceus Baltbio02 on the Health Status of Calves.
- Intense calf rearing which is now widely applied, causes gut microflora imbalance, since the appropriate microflora, which is formed from the environment and is obtained with maternal milk in the gastrointestinal tract of the livestock reared under the natural conditions, fails to develop in the gastrointestinal tract of the intensively reared livestock. For various reasons, changes in the composition of microorganisms of small intestine result in growth of coliform baccili which replace the lactic acid bacteria.
- the LAB materials are able to normalize the gut microflora, improve the defensive features of the mucosa, promote nutrient assimilation and natural resistance as well as reduce the stress-induced consequences.
- milk composition fat content %, protein content % , lactose %, somatic cell count, (SCC) thousand/ml), urea, (mg/per cent).
- SCC somatic cell count
- urea urea
- Example 3 Milk Yield and Chemical Composition when Feeding Cows with the Pediococcus pentosaceus Additive. Methodology of the Experiment of Feeding Lithuanian Black-and- White Cows with the LAB Pediococcus pentosaceus BaltBio02 Amplified and Prepared for Fermentation.
- the experimental cows were fed with the same ration. However, in addition to the feed, these cows were given 100 g of the experimental additive consisting of Pediococcus pentosaceus
- the milk yield was measured three times, i.e. at the beginning of the experiment, in the middle of the experiment (after a half of the experimental period) and at the end of the experiment by carrying out the control milkings.
- the quantity of milk with natural fat content was recalculated into the quantity of 4 per cent fat (corrected) milk on the basis of the respective ratios.
- Milk samples were taken from each cow individually in accordance with guidance on milk sampling (LST EN ISO 707: 1999+P:2003 Milk and milk products. Guidance on sampling) at the beginning, in the middle and at the end of the experiment. Milk fat content, milk protein content, lactose and urea were measured by using the device "LactoScope FTIR" (FT1.0.
- the LAB strains P. acidilactici BaltBioOl and P. pentosaceus BaltBio02 which have been isolated from the Lithuanian cereal raw material and tested, are microbiologically safer, have high biological activity and improve the health status of animals, increase their yield and may be successfully used in fermented feed production.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Microbiology (AREA)
- Food Science & Technology (AREA)
- Animal Husbandry (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- General Engineering & Computer Science (AREA)
- Botany (AREA)
- Mycology (AREA)
- General Health & Medical Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Sustainable Development (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Fodder In General (AREA)
Abstract
Description
Claims
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
LT2014109A LT6270B (en) | 2014-09-24 | 2014-09-24 | Probiotic fermented feed additives |
PCT/IB2015/057168 WO2016046706A1 (en) | 2014-09-24 | 2015-09-17 | Probiotic fermented feed additives |
Publications (1)
Publication Number | Publication Date |
---|---|
EP3198040A1 true EP3198040A1 (en) | 2017-08-02 |
Family
ID=54347594
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP15784768.2A Withdrawn EP3198040A1 (en) | 2014-09-24 | 2015-09-17 | Probiotic fermented feed additives |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP3198040A1 (en) |
EA (1) | EA201790685A1 (en) |
LT (1) | LT6270B (en) |
WO (1) | WO2016046706A1 (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
LT6271B (en) | 2014-09-24 | 2016-05-10 | Uab "Baltijos Biotechnologijos" | Fermented feed of plant origin |
LT6480B (en) | 2017-04-10 | 2017-12-11 | Aleksandro Stulginskio Universitetas | Dehydrated meadow grass meal |
WO2018224420A1 (en) | 2017-06-06 | 2018-12-13 | Chr. Hansen A/S | A pediococcus acidilactici strain capable of increasing milk yield |
CN109439565A (en) * | 2018-09-14 | 2019-03-08 | 湖南师范大学 | One plant of Pediococcus pentosaceus bacterial strain, its probiotics and preparation method thereof |
CN111406856B (en) * | 2020-03-11 | 2023-04-07 | 天津科技大学 | Functional fermented beverage for dispelling effects of alcohol and protecting liver and preparation method thereof |
CN112159460B (en) * | 2020-09-29 | 2021-12-17 | 厦门大学 | Scylla paramamosain antibacterial peptide Spamprin4-23And uses thereof |
CN116622580B (en) * | 2023-05-12 | 2025-02-11 | 山东省农业科学院畜牧兽医研究所 | A strain of Pediococcus pentosaceus PKC10 and its application |
CN118185811B (en) * | 2024-03-13 | 2024-08-02 | 广东海洋大学 | Fermented feed rich in antibacterial peptide, preparation method and application |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SU378405A1 (en) * | 1971-01-07 | 1973-04-18 | Всесоюзный научно исследовательский институт биосинтеза белковых веществ | METHOD OF CULTIVATION OF MICROORGANISMSI2 |
US20050130288A1 (en) * | 2003-12-11 | 2005-06-16 | Eromlife Co., Ltd. | Novel microorganism Pediococcus pentosaceus EROM101, having immune enhancement, anticancer and antimicrobial activities |
CN101489410B (en) | 2006-07-14 | 2013-09-18 | 隆娜·莱加斯 | Homofermentative product |
WO2012127004A1 (en) | 2011-03-22 | 2012-09-27 | Fermentationexperts A/S | Improved fermentation of protein-rich feed |
WO2013029682A1 (en) | 2011-09-01 | 2013-03-07 | Schaeffler Technologies AG & Co. KG | Drive device |
CN103173373B (en) * | 2012-07-12 | 2015-05-20 | 北京伟嘉人生物技术有限公司 | Pediococcus acidilactici with high bacteriostatic activity and application thereof |
CN103156091B (en) * | 2013-03-20 | 2014-09-10 | 哈尔滨市乳家科技饲料有限公司 | Method for manufacturing biologically-fermented straw nutrition forage grass at low temperature for beef |
-
2014
- 2014-09-24 LT LT2014109A patent/LT6270B/en not_active IP Right Cessation
-
2015
- 2015-09-17 WO PCT/IB2015/057168 patent/WO2016046706A1/en active Application Filing
- 2015-09-17 EP EP15784768.2A patent/EP3198040A1/en not_active Withdrawn
- 2015-09-17 EA EA201790685A patent/EA201790685A1/en unknown
Non-Patent Citations (2)
Title |
---|
None * |
See also references of WO2016046706A1 * |
Also Published As
Publication number | Publication date |
---|---|
LT6270B (en) | 2016-05-10 |
LT2014109A (en) | 2016-04-11 |
EA201790685A1 (en) | 2017-07-31 |
WO2016046706A1 (en) | 2016-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US10251920B2 (en) | Bacteria isolated from fresh honey or the honey producing tract of honey bees | |
WO2016046706A1 (en) | Probiotic fermented feed additives | |
CN110964655B (en) | Bifidobacterium lactis BL-99 and application thereof | |
CN113388550B (en) | Lactobacillus salivarius NHE-LsE33 and application thereof | |
KR20130113037A (en) | Novel bacillus subtilis | |
CN114134083A (en) | Bacillus belgii and application thereof | |
CN113040390A (en) | Probiotic and salt-tolerant Lactobacillus johnsonii strain and application thereof in prevention and treatment of pathogenic bacteria in livestock and poultry aquaculture | |
JP4199685B2 (en) | New lactic acid bacteria | |
KR101818859B1 (en) | Pseudomonas azotoformans strain KACC 92125P and composition for comprising the same | |
WO2016046708A1 (en) | Fermented feed of plant origin | |
KR20180004532A (en) | Bacillus safensis strain KACC 92124P and composition for comprising the same | |
US10166262B2 (en) | Strain of bacteria and composition comprising the same | |
EP3168292B1 (en) | New lactobacillus plantarum strain amt14 and composition containing the strain of lactobacillus plantarum amt14 | |
Manguntungi et al. | The profile analysis of lactic acid bacteria (LAB) from Sumbawa white honey and its potential producing antibacterial compounds | |
CN116004430B (en) | Lactobacillus plantarum NHE-LpE9 and application thereof | |
KR20210063994A (en) | Feed additives for animal containing Lactobacillus paracasei NSMJ15 | |
CN113604387A (en) | A salt- and high-temperature-resistant Lactobacillus reuteri and its application in controlling pathogenic bacteria in livestock and poultry aquaculture | |
KR20210076221A (en) | Pediococcus pentosaceus TC48 an composition containing the same | |
CN115851494B (en) | A strain of Lactobacillus plantarum NHE-LpE5 and its application | |
CN115992066B (en) | Lactobacillus paracasei NHB-LpD2 for liquid fermented feed and application | |
Chandra et al. | Development and assessment of a fish feed to assist in aquaculture nutrition management | |
RU2799554C1 (en) | New probiotic based on a consortium of spore-forming bacteria for aquaculture and animals and a method of its production | |
Theingi et al. | Efficacy of Lactic Acid Bacteria from Edible Fruits Against Antibiotics and Pathogenic Bacteria | |
Abareethan et al. | Effective role of probiotic isolate Bacillus sp. on the growth of Labeo rohita | |
KR100490284B1 (en) | New acid tolerant probiotic enterococcus faecalis probio-64 that can suppress the growth of porcine reproductive and respiratory syndrome virus |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE |
|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE |
|
17P | Request for examination filed |
Effective date: 20170406 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR |
|
AX | Request for extension of the european patent |
Extension state: BA ME |
|
DAV | Request for validation of the european patent (deleted) | ||
DAX | Request for extension of the european patent (deleted) | ||
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: EXAMINATION IS IN PROGRESS |
|
17Q | First examination report despatched |
Effective date: 20180716 |
|
GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: GRANT OF PATENT IS INTENDED |
|
RIC1 | Information provided on ipc code assigned before grant |
Ipc: A23K 10/12 20160101ALI20190625BHEP Ipc: A23K 10/35 20160101ALI20190625BHEP Ipc: C12R 1/225 20060101AFI20190625BHEP Ipc: A23K 30/18 20160101ALI20190625BHEP |
|
INTG | Intention to grant announced |
Effective date: 20190716 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20191127 |